| Application no. and date | 05805643.3 (espacenet) (Federated) (European Patent Register), 20050926 | | Patent/reg. no. and date | DK/EP 1794126, 20130320 | | Publication date | 20070613 | | Priority no. and date | US 614014 P, 20040927 | | EP pub. no. and date |
EP 1794126 20070613 | | Effective date | | | Applicant/owner | Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400
San Diego, CA 92130 California, US | | Applicant ref. no. | ACAD 058VEP | | Inventor | BLATTER, Fritz, Oerinstrasse 67
CH-4153 Reinach, CH,
BERGHAUSEN, Jörg, Eckenbachweg 17
79541 Lörrach, DE,
SCHLIENGER, Nathalie, Falstersvej 2, 1.tv., 2000 Frederiksberg, DK,
THYGESEN, Mikkel, Silkeborggade 20, st. th., 2100 København Ø, DK,
ANDERSSON, Carl-magnus, A., Ferievagen 3
S-SE-245 Hjarup, SE,
TOLF, Bo-ragnar, Kopenhamnsvagen 9C
S-217 43 Malmo, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4468 (2006.01) , A61P 25/00 (2006.01) , A61P 7/02 (2006.01) , C07D 211/58 (2006.01) | | Title | Krystallinsk form af N-(-4-fluorbenzyl)-N-(1-methylpiperidn-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamid-hemitartrat | | Int. application no. | US2005034813 | | Int. publication no. | WO2006037043 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
